Welcome to our dedicated page for Origin Agritech SEC filings (Ticker: SEED), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Origin Agritech Limited (NASDAQ: SEED) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as a foreign private issuer. Origin Agritech is a Beijing-based agricultural technology company focused on corn seed biotechnologies, GMO traits, and advanced breeding platforms, and its filings with the U.S. Securities and Exchange Commission offer structured insight into these activities.
Origin submits reports on Form 6-K under the Securities Exchange Act of 1934. Recent Form 6-K filings described unaudited financial results for the six months ended March 31, 2025, including condensed statements of operations, balance sheets, cash flows, and notes to the condensed consolidated financial statements. These documents outline the company’s reported revenue, operating expenses, operating results, and liquidity position over the period.
Other Form 6-K reports detail capital and governance actions, such as a modification of a securities purchase agreement with investors, the sale of ordinary shares to the company’s chief executive officer, and the adoption of a remuneration plan for independent directors. These filings specify share amounts, purchase prices, intended use of proceeds, and the structure of director compensation under a performance equity plan.
On Stock Titan, SEED filings are updated as they are released on EDGAR. Users can review Form 6-K exhibits, including financial results overviews and unaudited financial statements, alongside narrative descriptions of transactions and board decisions. AI-powered summaries help explain key points in each filing, such as the nature of share issuances, changes in director compensation, or the scope of financial disclosures, so readers can more quickly understand the implications of Origin Agritech’s regulatory reports.
For investors researching SEED, this page serves as a centralized view of Origin Agritech’s SEC-reported financial condition, capital transactions, and governance-related information.
Origin Agritech Limited has approved and executed a private placement of up to 2,000,000 ordinary shares at US$1.40 per share, for projected gross proceeds of US$2,800,000. On February 1, 2026, the company signed three Securities Purchase Agreements with two individuals and one investment company to sell these shares, with payments in two installments scheduled for February and August 2026.
The company plans to use the cash for general working capital and to expand its research and development activities. The shares are being issued as restricted securities under an exemption from registration. One agreement with Quality Reliance International Limited covers 800,000 shares for a subscription amount of US$1,120,000. As of this agreement date, Origin Agritech had 12,144,586 ordinary shares issued and outstanding.
Origin Agritech Limited, a British Virgin Islands holding company operating mainly in China through subsidiaries and VIEs, reports weaker results and highlights significant regulatory and structural risks. For the year ended September 30, 2025, revenue was RMB 91,290 thousand (about US$12,848), down from RMB 113,381 thousand in 2024, as gross profit fell to RMB 6,393 thousand.
Operating expenses rose to RMB 64,182 thousand, leading to a loss from operations of RMB 57,789 thousand. Net loss attributable to Origin shareholders was RMB 53,328 thousand, versus net income of RMB 20,712 thousand a year earlier. The company shows a working capital deficit of RMB 83,256 thousand and shareholders’ deficit of RMB 23,336 thousand, and its auditors included a going concern statement.
Origin uses a VIE structure to control seed-related operations that foreign investors cannot directly own under PRC law. The company stresses that investors hold equity in the BVI parent, not the PRC VIEs, and warns that adverse PRC actions on VIEs, CSRC/CAC filings, seed licenses, data security, or overseas listings could materially impair operations or even render the ordinary shares worthless. It also notes HFCAA-related risks are currently mitigated because its PCAOB-registered auditor is headquartered in Singapore.
Origin Agritech Limited filed Amendment No. 2 to a Form F-3 shelf to register up to $30,000,000 of ordinary shares, warrants, and units, to be offered from time to time for three years after effectiveness.
The company may sell these securities directly, through agents or dealers, or via underwriters, with specific terms and any net proceeds disclosed in a future prospectus supplement. Its ordinary shares trade on Nasdaq as SEED; on October 10, 2025, the closing price was $1.44.
Origin is a British Virgin Islands holding company whose operations are in China, including through variable interest entities (the VIE portion is Hainan Aoyu). On September 19, 2025, Origin Biotechnology updated its VIE contractual framework (proxy/POA, share pledge, master exclusive service, business cooperation, and exclusive option agreements), which together provide contractual control and economic benefits and support consolidation under U.S. GAAP.
The filing highlights PRC-related risks, including required CSRC filings within three business days after each issuance and reliance on a Seed Production and Operation License. The auditor is Enrome LLP (Singapore), registered with the PCAOB, and the company states it has not been identified as a Commission‑Identified Issuer under the HFCAA.
Origin Agritech Limited reports several corporate actions involving new share issuances and director compensation. The company modified an existing August 2024 share sale agreement so it will now sell an aggregate of 1,234,300 ordinary shares to two investors at an adjusted price of $1.20 per share, for total consideration of USD$1,481,250. These shares are being issued as restricted stock under an exemption from the Securities Act of 1933, without registration rights.
The Board also approved the sale of 2,000,000 ordinary shares to Chief Executive Officer and Director Mr. Yan Weibin at $1.20 per share, for gross proceeds of $2,400,000. The company plans to use these proceeds for general corporate purposes and repayment of outstanding debt. In addition, the Board adopted a new remuneration plan for independent directors under the 2024 Performance Equity Plan, providing yearly cash payments of USD$18,000 plus 2,000 shares and 2,000 options for each non‑employee director and certain committee chairs, and USD$30,000 plus 2,000 shares and 2,000 options for the Audit Committee Chairman.